Clinical Trial Update: Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS) [Phase 2]

View source ↗

Summary

Phase 2 trial for ATI-450 in Cryopyrin-Associated Periodic Syndrome was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryopyrin-associated Periodic Syndrome

Drugs mentioned

• ATI-450

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Cryopyrin-Associated Periodic Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2023-09-21